Researchers say the two-drug combination pill known as BiDil successfully reduces deaths among African-American heart failure patients. But the study, recently published in The New England Journal of Medicine, has its fair share of critics. NPR's Tavis Smiley discusses the controversy with regular health commentator Dr. Ian Smith, columnist for Men's Health magazine and The New York Daily News.
Copyright 2004 NPR
